{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:17:39Z","timestamp":1790320659425,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.amjmed.2016.09.028","type":"journal-article","created":{"date-parts":[[2016,10,28]],"date-time":"2016-10-28T01:02:03Z","timestamp":1477616523000},"page":"365.e13-365.e18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["A Systematic Analysis of Treatment and Outcomes of NOD2-Associated Autoinflammatory Disease"],"prefix":"10.1016","volume":"130","author":[{"given":"Qingping","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2016.09.028_bib1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.autrev.2012.07.018","article-title":"Autoinflammation and autoimmunity: bridging the divide","volume":"12","author":"Doria","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.amjmed.2016.09.028_bib2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0092-8674(00)80721-7","article-title":"Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes","volume":"97","author":"McDermott","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.amjmed.2016.09.028_bib3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00281-015-0478-4","article-title":"Update on genetics and pathogenesis of autoinflammatory diseases: the last 2 years","volume":"37","author":"Aksentijevich","year":"2015","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.amjmed.2016.09.028_bib4","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1074\/jbc.M008072200","article-title":"Nod2, a Nod1\/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB","volume":"276","author":"Ogura","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.amjmed.2016.09.028_bib5","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/gut.49.6.752","article-title":"NOD2 (CARD15), the first susceptibility gene for Crohn's disease","volume":"49","author":"McGovern","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.amjmed.2016.09.028_bib6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.semarthrit.2012.12.005","article-title":"Nucleotide-binding oligomerization domain containing 2: structure, function, and diseases","volume":"43","author":"Yao","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.amjmed.2016.09.028_bib7","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/35079107","article-title":"Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease","volume":"411","author":"Hugot","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.amjmed.2016.09.028_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng720","article-title":"CARD15 mutations in Blau syndrome","volume":"29","author":"Miceli-Richard","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.amjmed.2016.09.028_bib9","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1093\/rheumatology\/kev207","article-title":"NOD2-associated autoinflammatory disease: a large cohort study","volume":"54","author":"Yao","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"suppl 10","key":"10.1016\/j.amjmed.2016.09.028_bib10","article-title":"NOD2-associated autoinflammatory disease: therapy and outcomes","volume":"67","author":"Yao","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.amjmed.2016.09.028_bib11","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jaad.2012.09.025","article-title":"Dermatitis as a characteristic phenotype of a new autoinflammatory disease associated with NOD2 mutations","volume":"68","author":"Yao","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.amjmed.2016.09.028_bib12","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.semarthrit.2015.10.012","article-title":"Adult autoinflammatory disease frequency and our diagnostic experience in an adult autoinflammatory clinic","volume":"45","author":"Yao","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.amjmed.2016.09.028_bib13","doi-asserted-by":"crossref","first-page":"R148","DOI":"10.1186\/ar3462","article-title":"A\u00a0new category of autoinflammatory disease associated with NOD2 gene mutations","volume":"13","author":"Yao","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.amjmed.2016.09.028_bib14","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1093\/rheumatology\/ket143","article-title":"Distal lower extremity swelling as a prominent phenotype of NOD2-associated autoinflammatory disease","volume":"52","author":"Yao","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.amjmed.2016.09.028_bib15","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/FPC.0b013e3283299a73","article-title":"Genomic analysis of sulfasalazine effect in experimental colitis is consistent primarily with the modulation of NF-kappaB but not PPAR-gamma signaling","volume":"19","author":"Martinez-Augustin","year":"2009","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.amjmed.2016.09.028_bib16","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/labinvest.2013.99","article-title":"NOD2 deletion promotes cardiac hypertrophy and fibrosis induced by pressure overload","volume":"93","author":"Zong","year":"2013","journal-title":"Lab Invest"},{"key":"10.1016\/j.amjmed.2016.09.028_bib17","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s10753-014-0038-4","article-title":"Aberrant expression of regulatory cytokine IL-35 and pattern recognition receptor NOD2 in patients with allergic asthma","volume":"38","author":"Wong","year":"2015","journal-title":"Inflammation"},{"key":"10.1016\/j.amjmed.2016.09.028_bib18","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jaip.2016.02.016","article-title":"NOD2-associated autoinflammatory disease and immune deficiency","volume":"4","author":"Yao","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.amjmed.2016.09.028_bib19","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1365-2249.2010.04216.x","article-title":"NOD2 polymorphisms in clinical phenotypes of common variable immunodeficiency disorders","volume":"161","author":"Packwood","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.amjmed.2016.09.028_bib20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.bpg.2014.04.009","article-title":"Genetic studies of Crohn's disease: past, present and future","volume":"28","author":"Liu","year":"2014","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.amjmed.2016.09.028_bib21","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/ng.952","article-title":"Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease","volume":"43","author":"Rivas","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.amjmed.2016.09.028_bib22","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0140-6736(06)68345-1","article-title":"New genes in inflammatory bowel disease: lessons for complex diseases?","volume":"367","author":"Gaya","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2016.09.028_bib23","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0140-6736(06)68265-2","article-title":"Defective acute inflammation in Crohn's disease: a clinical investigation","volume":"367","author":"Marks","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2016.09.028_bib24","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1073\/pnas.0530276100","article-title":"Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases","volume":"100","author":"Chamaillard","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.amjmed.2016.09.028_bib25","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/rheumatology\/ket384","article-title":"NOD2-associated autoinflammatory disease: an exploratory study of its pathogenesis","volume":"53","author":"Yao","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"suppl 10","key":"10.1016\/j.amjmed.2016.09.028_bib26","article-title":"Functional consequences of NOD2 gene variants in patients with NOD2-associated autoinflammatory disease","volume":"67","author":"McDonald","year":"2015","journal-title":"Arthritis Rheumatol"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934316310634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934316310634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:10:35Z","timestamp":1757581835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934316310634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0002934316310634"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2016.09.028","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Systematic Analysis of Treatment and Outcomes of NOD2-Associated Autoinflammatory Disease","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2016.09.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}